Tissue Pattern Recognition Error Rates and Tumor Heterogeneity in Gastric Cancer

The anatomic pathology discipline is slowly moving toward a digital workflow, where pathologists will evaluate whole-slide images on a computer monitor rather than glass slides through a microscope. One of the driving factors in this workflow is computer-assisted scoring, which depends on appropriate selection of regions of interest. With advances in tissue pattern recognition techniques, a more precise region of the tissue can be evaluated, no longer bound by the pathologist’s patience in manually outlining target tissue areas. Pathologists use entire tissues from which to determine a score in a region of interest when making manual immunohistochemistry assessments. Tissue pattern recognition theoretically offers this same advantage; however, error rates exist in any tissue pattern recognition program, and these error rates contribute to errors in the overall score. To provide a real-world example of tissue pattern recognition, 11 HER2-stained upper gastrointestinal malignancies with high heterogeneity were evaluated. HER2 scoring of gastric cancer was chosen due to its increasing importance in gastrointestinal disease. A method is introduced for quantifying the error rates of tissue pattern recognition. The trade-off between fully sampling tumor with a given tissue pattern recognition error rate versus randomly sampling a limited number of fields of view with higher target accuracy was modeled with a Monte-Carlo simulation. Under most scenarios, stereological methods of sampling-limited fields of view outperformed whole-slide tissue pattern recognition approaches for accurate immunohistochemistry analysis. The importance of educating pathologists in the use of statistical sampling is discussed, along with the emerging role of hybrid whole-tissue imaging and stereological approaches.

[1]  Andrew H. Beck,et al.  Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival , 2011, Science Translational Medicine.

[2]  A. Winsor Sampling techniques. , 2000, Nursing times.

[3]  J. Hedreen,et al.  Unbiased stereology? , 1999, Trends in Neurosciences.

[4]  Steven J Potts,et al.  The role and impact of quantitative discovery pathology. , 2010, Drug discovery today.

[5]  Luis M. Cruz-Orive,et al.  On the precision of systematic sampling: a review of Matheron's transitive methods , 1989 .

[6]  M. Vijver,et al.  HER2 testing in gastric cancer: a practical approach , 2012, Modern Pathology.

[7]  H. Gundersen,et al.  The efficiency of systematic sampling in stereology — reconsidered , 1999, Journal of microscopy.

[8]  M. J. van de Vijver,et al.  Assessment of a HER2 scoring system for gastric cancer: results from a validation study , 2008, Histopathology.

[9]  Holger Lange Digital Pathology: A Regulatory Overview , 2011 .

[10]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[11]  Y. Bang,et al.  Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma , 2011, Histopathology.

[12]  J. E. Gardi,et al.  The proportionator: Unbiased stereological estimation using biased automatic image analysis and non-uniform probability proportional to size sampling , 2008, Comput. Biol. Medicine.

[13]  Mehmet Toner,et al.  Spatially Invariant Vector Quantization: A pattern matching algorithm for multiple classes of image subject matter including pathology , 2011, Journal of pathology informatics.

[14]  D. Hicks,et al.  HER2 testing in gastric and esophageal adenocarcinoma: new diagnostic challenges arising from new therapeutic options , 2012, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[15]  D. Hicks,et al.  HER2 Testing in Gastric and Gastroesophageal Junction Cancers: A New Therapeutic Target and Diagnostic Challenge , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[16]  Holger Lange,et al.  Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue , 2012, Laboratory Investigation.

[17]  Holger Lange,et al.  Reading Immunohistochemical Slides on a Computer Monitor—A Multisite Performance Study Using 180 HER2-stained Breast Carcinomas , 2011, Applied immunohistochemistry & molecular morphology : AIMM.

[18]  Holger Lange,et al.  Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens. , 2011, Archives of pathology & laboratory medicine.

[19]  Neal R. Harvey,et al.  Comparison of GENIE and conventional supervised classifiers for multispectral image feature extraction , 2002, IEEE Trans. Geosci. Remote. Sens..

[20]  Arvydas Laurinavicius,et al.  Digital Image Analysis in Pathology: Benefits and Obligation , 2011, Analytical cellular pathology.